Celltheon
As the VP of Business Development, Divya has served in a key role overseeing platform development and licensing for Celltheon. As a bioprocess engineer by training, Divya is not only involved in external-facing business opportunities, she also works with the technical staff to evaluate new bioprocessing technologies and develop efficient workflows that can be leveraged by the greater Pharmaceutical Industry. Divya holds a BS in Biology from Drexel University and a Master’s in Business and Science (MBS) from Keck Graduate Institute in Bioprocess Engineering and Business. Since joining Celltheon, many of the client molecules she has overseen have advanced into late-stage development. Divya is committed to overseeing the application of Celltheon’s novel technologies to develop high titer, high-quality products and ensure seamless tech transfer.
This person is not in any offices
Celltheon
Celltheon has been developing Cell Engineering technologies since 2012. Celltheon has patents, granted and pending, for its CHOK-1 derived SUPERCELL™ cell line and its unique DNA and RNA vector elements that are applicable for recombinant biotherapeutics such as Mabs, Difficult to Express Proteins (DEP) as well as for CAR-T, Gene Therapy, and Cell Factories applications.